NCT04351256
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04351256
Title Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy (TRADE-hypo)
Acronym TRADE-hypo
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Aachen Aachen 52074 Germany Details
DRK Kliniken Berlin-Mitte Berlin 13359 Germany Details
Kliniken der Stadt Köln gGmbH, Lungenklinik Merheim Cologne 51109 Germany Details
Universitätsmedizin Göttingen Göttingen 37075 Germany Details
Onkodok GmbH Gütersloh 33332 Germany Details
Thoraxklinik am Universitätsklinikum Heidelberg Heidelberg 69126 Germany Details
Lungenklinik Hemer, Pneumologie und Thorakale Onkologie Hemer 58675 Germany Details
Vincentius-Diakonissen-Kliniken gAG Karlsruhe 76137 Germany Details
Klinikum Ludwigsburg Ludwigsburg 71640 Germany Details
Universitätsmedizin Mainz Mainz 55131 Germany Details
Kliniken Maria Hilf GmbH Mönchengladbach 41063 Germany Details
Gemeinschaftspraxis für Hämatologie und Onkologie Münster 48153 Germany Details
Sana Klinikum Offenbach GmbH Offenbach 63069 Germany Details
Pi.Tri-Studien GmbH Offenburg 77654 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field